相似文献
1
Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York.
Antimicrob Agents Chemother. 2005 Feb;49(2):776-8. doi: 10.1128/AAC.49.2.776-778.2005.
2
Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp.
Antimicrob Agents Chemother. 2004 Nov;48(11):4438-40. doi: 10.1128/AAC.48.11.4438-4440.2004.
3
Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.
Antimicrob Agents Chemother. 2004 Dec;48(12):4793-9. doi: 10.1128/AAC.48.12.4793-4799.2004.
4
Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection.
Antimicrob Agents Chemother. 2005 Jul;49(7):3018-20. doi: 10.1128/AAC.49.7.3018-3020.2005.
5
[Detection of plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae].
Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):135-8.
6
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.
Clin Infect Dis. 2004 Jul 1;39(1):55-60. doi: 10.1086/421495. Epub 2004 Jun 14.
7
Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York.
Clin Infect Dis. 2007 Apr 1;44(7):972-5. doi: 10.1086/512370. Epub 2007 Feb 21.
8
Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 and ArmA 16S rRNA methylase conferring high-level aminoglycoside resistance in carbapenem-resistant Enterobacter cloacae in China.
Diagn Microbiol Infect Dis. 2010 Mar;66(3):326-8. doi: 10.1016/j.diagmicrobio.2009.10.003. Epub 2009 Nov 10.
9
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.
Arch Intern Med. 2005 Jun 27;165(12):1430-5. doi: 10.1001/archinte.165.12.1430.
10
Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates.
Diagn Microbiol Infect Dis. 2007 Jan;57(1):85-91. doi: 10.1016/j.diagmicrobio.2006.05.008. Epub 2006 Jul 18.
引用本文的文献
1
carbapenemase variants: the new threat to global public health.
Clin Microbiol Rev. 2023 Dec 20;36(4):e0000823. doi: 10.1128/cmr.00008-23. Epub 2023 Nov 8.
2
Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens.
Int J Mol Sci. 2020 Nov 12;21(22):8527. doi: 10.3390/ijms21228527.
3
spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance.
Clin Microbiol Rev. 2019 Jul 17;32(4). doi: 10.1128/CMR.00002-19. Print 2019 Sep 18.
4
Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria.
Antibiotics (Basel). 2019 Apr 6;8(2):37. doi: 10.3390/antibiotics8020037.
5
Development of a Novel Loop-Mediated Isothermal Amplification Method to Detect Guiana Extended-Spectrum (GES) β-Lactamase Genes in .
Front Microbiol. 2019 Feb 4;10:25. doi: 10.3389/fmicb.2019.00025. eCollection 2019.
6
MALDI-TOF MS Identification and Clustering Applied to Species in Nosocomial Setting.
Front Microbiol. 2018 Aug 14;9:1885. doi: 10.3389/fmicb.2018.01885. eCollection 2018.
7
The Immaculate Carbapenemase Study.
J Clin Microbiol. 2017 Jun;55(6):1608-1611. doi: 10.1128/JCM.00430-17. Epub 2017 Apr 12.
8
Clonality, outer-membrane proteins profile and efflux pump in KPC- producing Enterobacter sp. in Brazil.
BMC Microbiol. 2017 Mar 17;17(1):69. doi: 10.1186/s12866-017-0970-1.
9
Comprehensive Genome Analysis of Carbapenemase-Producing Enterobacter spp.: New Insights into Phylogeny, Population Structure, and Resistance Mechanisms.
mBio. 2016 Dec 13;7(6):e02093-16. doi: 10.1128/mBio.02093-16.
10
Emerging Issues and Treatment Strategies in Carbapenem-Resistant Enterobacteriaceae (CRE).
Curr Infect Dis Rep. 2016 Dec;18(12):48. doi: 10.1007/s11908-016-0548-3.
本文引用的文献
1
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.
Clin Infect Dis. 2004 Jul 1;39(1):55-60. doi: 10.1086/421495. Epub 2004 Jun 14.
2
Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.
Antimicrob Agents Chemother. 2003 Dec;47(12):3881-9. doi: 10.1128/AAC.47.12.3881-3889.2003.
3
Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases.
Antimicrob Agents Chemother. 2003 Nov;47(11):3554-60. doi: 10.1128/AAC.47.11.3554-3560.2003.
4
NmcA carbapenem-hydrolyzing enzyme in Enterobacter cloacae in North America.
Emerg Infect Dis. 2003 Aug;9(8):999-1002. doi: 10.3201/eid0908.030096.
5
Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City.
Clin Infect Dis. 2003 Jul 15;37(2):214-20. doi: 10.1086/375821. Epub 2003 Jul 9.
6
Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2.
Antimicrob Agents Chemother. 2003 Apr;47(4):1297-300. doi: 10.1128/AAC.47.4.1297-1300.2003.
7
Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates.
J Antimicrob Chemother. 2003 Mar;51(3):711-4. doi: 10.1093/jac/dkg124.
8
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002.
Am J Infect Control. 2002 Dec;30(8):458-75. doi: 10.1067/mic.2002.130032.
9
Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs.
Antimicrob Agents Chemother. 2002 Dec;46(12):3817-22. doi: 10.1128/AAC.46.12.3817-3822.2002.
10
Molecular epidemiology of a citywide outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection.
Clin Infect Dis. 2002 Oct 1;35(7):834-41. doi: 10.1086/342577. Epub 2002 Sep 10.
Zotero 插件